These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23665785)

  • 1. Where next for the Cancer Drugs Fund?
    Joffe J
    Br J Hosp Med (Lond); 2013 Mar; 74(3):156-9. PubMed ID: 23665785
    [No Abstract]   [Full Text] [Related]  

  • 2. Number of patients eligible for fast track access to drugs through the cancer drugs fund is slashed.
    Torjesen I
    BMJ; 2013 Apr; 346():f2197. PubMed ID: 23568803
    [No Abstract]   [Full Text] [Related]  

  • 3. Top-up insurance for cancer drugs.
    Sikora K
    Br J Hosp Med (Lond); 2007 Jun; 68(6):288-9. PubMed ID: 17639822
    [No Abstract]   [Full Text] [Related]  

  • 4. Government's fund is improving access to drugs for patients with cancer.
    Kmietowicz Z
    BMJ; 2011 Dec; 343():d7918. PubMed ID: 22144413
    [No Abstract]   [Full Text] [Related]  

  • 5. NHS England drops 16 medicines from Cancer Drugs Fund.
    Hawkes N
    BMJ; 2015 Sep; 351():h4803. PubMed ID: 26345321
    [No Abstract]   [Full Text] [Related]  

  • 6. MPs find no evidence that Cancer Drugs Fund was spent wisely.
    Hawkes N
    BMJ; 2016 Feb; 352():i755. PubMed ID: 26850036
    [No Abstract]   [Full Text] [Related]  

  • 7. Report highlights European inequalities in access to cancer drugs.
    Eur J Cancer; 2005 Dec; 41(18):2779. PubMed ID: 16408332
    [No Abstract]   [Full Text] [Related]  

  • 8. Having "Skin in the Game" and Allowing Cross-Border Importation of Drugs to Lower High Prices of Cancer Drugs.
    Kantarjian H; Mathisen MS; Lipton JH
    JAMA Oncol; 2015 Sep; 1(6):729-30. PubMed ID: 26182331
    [No Abstract]   [Full Text] [Related]  

  • 9. Differences in availability of cancer drugs across Europe.
    Mayor S
    Lancet Oncol; 2016 Sep; 17(9):1196. PubMed ID: 27476616
    [No Abstract]   [Full Text] [Related]  

  • 10. Access to cancer drugs: local autonomy or local tyranny?
    Waxman J
    Br J Hosp Med (Lond); 2008 Aug; 69(8):436-7. PubMed ID: 18783089
    [No Abstract]   [Full Text] [Related]  

  • 11. Access to cancer drugs: local autonomy or local tyranny?
    Dillon A
    Br J Hosp Med (Lond); 2008 Sep; 69(9):537; author reply 537. PubMed ID: 18822467
    [No Abstract]   [Full Text] [Related]  

  • 12. Access to cancer drugs: local autonomy or local tyranny?
    Sikora K
    Br J Hosp Med (Lond); 2008 Sep; 69(9):537; author reply 537. PubMed ID: 18819312
    [No Abstract]   [Full Text] [Related]  

  • 13. United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Strategy Group workshop. Improvements in patient access to new anti-cancer medicines.
    Br J Cancer; 1999 Jan; 79(1):2-3. PubMed ID: 10408683
    [No Abstract]   [Full Text] [Related]  

  • 14. At last, NICE to take over the Cancer Drugs Fund.
    Timmins N
    BMJ; 2016 Mar; 352():i1324. PubMed ID: 26951838
    [No Abstract]   [Full Text] [Related]  

  • 15. Access to expensive anti-cancer drugs.
    Mileshkin L; Sullivan D
    J Law Med; 2011 Dec; 19(2):232-43. PubMed ID: 22319998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No evidence that £1bn Cancer Drugs Fund has helped patients, says watchdog.
    Kmietowicz Z
    BMJ; 2015 Sep; 351():h4988. PubMed ID: 26384368
    [No Abstract]   [Full Text] [Related]  

  • 17. Most drugs paid for by £1.27bn Cancer Drugs Fund had no "meaningful benefit".
    Cohen D
    BMJ; 2017 Apr; 357():j2097. PubMed ID: 28455308
    [No Abstract]   [Full Text] [Related]  

  • 18. The Cancer Drug Fund 1 year on--success or failure?
    Stephens P; Thomson D
    Lancet Oncol; 2012 Aug; 13(8):754-7. PubMed ID: 22748755
    [No Abstract]   [Full Text] [Related]  

  • 19. Cancer drugs dropped from 'unsustainable' fund list.
    Nurs Stand; 2015 Sep; 30(4):10. PubMed ID: 26394942
    [No Abstract]   [Full Text] [Related]  

  • 20. Liver cancer drug is rejected for routine NHS use but will remain in Cancer Drugs Fund.
    Torjesen I
    BMJ; 2017 Jan; 356():i6864. PubMed ID: 28049164
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.